Endovia Health Sciences, Inc. — Form 8-K
Filed October 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed 2026-10-06 discloses Item 3.02 (unregistered sales of equity securities) for period ending 2026-09-30. The actual filing text does not contain specific dollar amounts, share counts, purchaser identities, or pricing terms — only structural metadata and XBRL exhibits are present. Without those concrete details, the substance of the transaction cannot be assessed.
Why this rating
Unregistered equity sales are routine disclosures for micro-cap firms; cannot assess magnitude without price/share/proceeds data; filing structure suggests standard reporting.
Extracted items
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.